English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

yelodysplastic syndrome (MDS)-myeloproliferative neolasm (MPN) with ringed sideroblasts and thrombocytosis MDS/MPN-RS-T) is a rare entity categorized under the yelodysplastic-myeloproliferative group (MDS/MPN) in the ecent 2016 World Health Organization (WHO) update on he classification of myeloid neoplasms.1 Initially named s refractory anemia with ringed sideroblasts associated ith marked thrombocytosis (RARS-T), it was a provisional ntity under MDS/MPN in the 2008 WHO classification of ematopoietic tumors. Patients with this condition have linico-morphological features of MDS (RARS) along with arked thrombocytosis and abnormal megakaryocytes simiar to those seen in breakpoint cluster region-Abelson murine eukemia-1 (BCR ABL1)-negative MPN.

hematology transfusion and cell therapy

Anemia with thrombocytosis in an elderly male: a case of myelodysplastic syndrome-myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis